It’s been 25 years since the International Diabetes Federation and the World Health Organization declared November 14 -- the birth date of Frederick Banting -- World Diabetes Day. While there have been incredible strides made for people affected by diabetes in the past quarter-century, it remains a global health challenge. And one we’re committed to fighting.
An estimated 415 million people around the world have diabetes, including roughly 60 million people across Europe. The enormity of those numbers is just one reason why Lilly Diabetes is thrilled to announce a partnership with the European Foundation for the Study of Diabetes (EFSD), a not-for-profit organization governed by the executive committee of the European Association for the Study of Diabetes (EASD).
The partnership includes a 3-year, 6 million euro commitment designed to drive new research and education to better support people with diabetes in Europe, and around the world. According to the Chairman of EFSD, Professor Stefano Del Prato, this partnership is “another step forward to link science, research, and education and to attract younger investigators in a very competitive field.”
Another reason we’re so enthusiastic about this partnership is because it exemplifies our ongoing commitment to collaborating across public and private sectors. Our work in this field started over 90 years ago, when we partnered with the University of Toronto to become the first in the world to deliver insulin to people with diabetes. By focusing on initiatives that will support educational institutions, we hope to support the growth of a new wave of innovative solutions to this skyrocketing global epidemic.
Today millions of people with diabetes do not receive adequate treatment or care, and in some instances are not even aware that they have diabetes. But we’re hopeful that by working hand-in-hand with EFSD we’ll be one step closer to fulfilling our promise to make life better for all those affected by diabetes around the world.